Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05897632 · ClinicalTrials.gov registry record · NA
CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)
A NA study of Chest Pain, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 502
- Enrollment target
- 3
- Study locations
NCT05897632: Recruiting NA study of Chest Pain, sponsored by Wake Forest University Health Sciences.
NCT05897632 is a NA study of Chest Pain that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 502 participants, below the 1,435-participant average among 22 other Chest Pain trials with a reported enrollment target (65% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05897632, a NA study of Chest Pain, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 502 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this study is to determine if rapid outpatient evaluation vs hospitalization management is the best strategy (based on patient-centered measures and safe, equitable, and efficient resource use) for evaluating patients with acute chest pain who are at moderate risk for acute coronary syndrome (ACS). Patients will be randomized in the Emergency Department to either an outpatient evaluation (CARE-CP) or hospitalization evaluation for their symptoms.
Primary Outcome
Time spent in a hospital setting at 30 days post-randomization will be measured and subtracted from time spent outside the hospital. Hospital time is broadly defined, based on a patient-centered definition of cumulative time spent in the ED, observation unit, or hospital ward. Consistent with prior trials, patients who experience death during the follow-up period are assigned zero HFDs.
Conditions Studied
Interventions
- BEHAVIORAL Outpatient Evaluation
- BEHAVIORAL Hospitalization Evaluation
Study Locations (3)
North Carolina
- Carolinas Medical Center - Charlotte
- Wake Forest University Health Sciences - Winston-Salem
Michigan
- Henry Ford Hospital - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 502 participants |
| Start Date | 2023-10-02 |
| Est. Completion | 2026-10 |
| Phase | NA |
What NCT05897632 shows while recruiting
NCT05897632 is an interventional study that assigns participants to a tested intervention. The registered 502 participants enrollment target is mid-sized for trials with a published cap, below the 1,435-participant average among 22 other Chest Pain trials with a reported enrollment target (65% lower).
The record links to 1 condition, with Chest Pain appearing as the primary indexed condition, and to 2 interventions - of which Outpatient Evaluation is the first listed.
NCT05897632 reports a single indexed study location in North Carolina, Michigan.
Frequently Asked Questions
What is clinical trial NCT05897632 about?
NCT05897632 is a clinical study titled "CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)". The goal of this study is to determine if rapid outpatient evaluation vs hospitalization management is the best strategy (based on patient-centered measures and safe, equitable, and efficient resource use) for evaluating patients with acute chest pain who are at moderate risk for acute coronary synd...
What is the current status of trial NCT05897632?
This trial is currently recruiting. It is a NA study. The enrollment target is 502 participants. The study started on 2023-10-02. Estimated completion is 2026-10.
What conditions does trial NCT05897632 study?
This clinical trial studies the following conditions: Chest Pain.
What interventions are being tested in trial NCT05897632?
The interventions under investigation include: Outpatient Evaluation (BEHAVIORAL), Hospitalization Evaluation (BEHAVIORAL).
Who is sponsoring clinical trial NCT05897632?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05897632 being conducted?
This trial has 3 study locations across Michigan, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chest Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05897632's enrollment target sits among peer trials
502 8th of 22 higher than 15 of 22 other Chest Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chest Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Virtual Reality for Non-cardiac Chest Pain
RECRUITING · NA
-
Intraoperative Echocardiography in Low-Risk CABG Surgery
ACTIVE NOT RECRUITING · NA
-
Patient-centered Treatment of Anxiety After Low-Risk Chest Pain in the Emergency Room
ACTIVE NOT RECRUITING · NA
-
Comparing Sports Bra Design in Full Busted Women
COMPLETED · NA
-
Chest Pain Perception and Capsaicin Sensitivity
COMPLETED · NA
-
Cost Comparison of Cardiac Magnetic Resonance Imaging (MRI) Use in Emergency Department (ED) Patients With Chest Pain
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05646381 · 502 participants · Phase 2
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
- NCT05143931 · 503 participants · NA
Avoid and Resist Strategies for Weight Management
- NCT04442022 · 501 participants · Phase 2
A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
- NCT06934525 · 501 participants · NA
Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI